ArticleInternational urology and nephrology2026
Occult pT2-4 disease and postoperative loss of full-dose cisplatin eligibility in CT-staged cT≤1/cN0 upper tract urothelial carcinoma.
Myung Soo Kim et al.PubMed ↗Publisher ↗
No numbers read from the abstract.